Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
Course Type: Live CME/CE Webinar
Number of Credits: 1
Credit Type: CME/CE-certified, MOC-eligible
DATES AND TIMES
Tuesday, September 15, 2020
4:00 – 5:00 PM ET
Tuesday, September 29, 2020
1:00 – 2:00 PM ET
Thursday, October 15, 2020
7:00 – 8:00 PM ET
Click here for accreditation information and to register
Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine requires special attention, particularly because symptoms of COVID-19 infection are similar to common adverse events associated with lung cancer treatment.
This activity, “Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide clinicians with the most up-to-date guidance on managing lung cancer during the current pandemic, including information on the pathophysiology of Sars-Cov-2, the risk of infection in patients with lung cancer, and strategies to manage patient care and counsel through telemedicine.
Some topics covered:
• The Pathophysiology of COVID-19
• Patient and Disease Features that Increase Risk of COVID-19 Infection and Complications in Patients with Lung Cancer
• Recommendations for Managing Patients with Lung Cancer in the COVID-19 Pandemic
Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
Course Type: Live CME/CE Webinar
Number of Credits: 1
Credit Type: CME/CE-certified, MOC-eligible
DATES AND TIMES
Tuesday, September 15, 2020
4:00 – 5:00 PM ET
Tuesday, September 29, 2020
1:00 – 2:00 PM ET
Thursday, October 15, 2020
7:00 – 8:00 PM ET
Click here for accreditation information and to register
Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine requires special attention, particularly because symptoms of COVID-19 infection are similar to common adverse events associated with lung cancer treatment.
This activity, “Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide clinicians with the most up-to-date guidance on managing lung cancer during the current pandemic, including information on the pathophysiology of Sars-Cov-2, the risk of infection in patients with lung cancer, and strategies to manage patient care and counsel through telemedicine.
Some topics covered:
• The Pathophysiology of COVID-19
• Patient and Disease Features that Increase Risk of COVID-19 Infection and Complications in Patients with Lung Cancer
• Recommendations for Managing Patients with Lung Cancer in the COVID-19 Pandemic